This Week in Family Medicine — Jun 7, 2026

Welcome to This Week in Family Medicine. This week we're covering 7 notable papers. We'll start with major global health updates, including the staggering 50-year return on investment from vaccination and a new look at the leading causes of death for children and adolescents. We'll then turn to practice-level interventions, with a major study on medically tailored meals and a trial that challenges our assumptions about dementia screening. Finally, a quick look at some foundational science in cancer biology. Let's dive in.

First up, we look at global health, starting with a major success story. A report in The Lancet Global Health provides an economic evaluation of the 50-year history of the Expanded Programme on Immunization, or EPI [2]. The results are stunning. From 1974 to 2024, the program, which covers 14 pathogens like measles, polio, and tetanus, cost about 937 billion dollars. However, it generated an estimated 15 trillion dollars in averted productivity losses by preventing deaths. This translates to a global benefit-cost ratio of 16, meaning every dollar invested returned 16 dollars in economic benefits. The impact was greatest in low-income countries, which saw a nearly 24-fold return on investment. The authors found that immunization against all 14 pathogens was economically favorable, with measles vaccination providing the single highest benefit-cost ratio of nearly 74. This analysis provides powerful evidence that the 50-year EPI has been a highly cost-effective, life-saving investment at every level.

But while vaccination has been a monumental success, other areas of global health face persistent challenges. A modeling study in the BMJ provides updated estimates for the causes of death among children and adolescents aged 5 to 19 across 195 countries [1]. In 2024, the leading global cause of death in this age group was road traffic injuries, accounting for over 113,000 deaths. This was followed by malaria and cancers. The analysis highlights a crucial shift in mortality patterns. While communicable and nutritional conditions still account for nearly half of deaths in 5 to 14-year-olds, they make up less than a quarter of deaths in older adolescents aged 15 to 19. In this older group, the causes diverge by sex: road traffic injuries were the leading killer of males, while self-harm was the most prevalent cause of death in females. The study also sounds an alarm that progress in reducing deaths from communicable diseases has slowed since 2015, underscoring the need to focus on previously lower-priority causes like cancer and injuries. Another concerning finding comes from a study in Nature Medicine, which examined the quality of childbirth care in three 'Exemplar' countries—Nepal, Senegal, and Zambia—known for their progress in maternal and newborn health [5]. The researchers found a stark gap between coverage and quality. While crude coverage by skilled health personnel ranged from 30% to 100% in different regions, the 'effective coverage'—meaning the delivery of actual, high-quality, life-saving care—was far lower, ranging from just 12% to 43%. This suggests that simply having a skilled attendant present does not guarantee quality care, and that this quality gap is a critical barrier to reducing maternal and neonatal mortality, even in high-performing low- and middle-income countries.

Turning from global health systems to interventions in the clinic, a study in Nature Medicine offers compelling evidence for the 'food is medicine' model [7]. Researchers evaluated the impact of providing medically tailored meals to over 1,800 Medicaid recipients in Massachusetts who had diet-related conditions and food insecurity. Compared to a similar group not receiving the meals, recipients saw 31% fewer hospitalizations and 20% fewer emergency department visits over an average of about 7 months. Critically, the associated healthcare cost reductions of over $3,400 per person offset 98% of the cost of the meal program. For participants with cardiovascular disease, chronic kidney disease, depression, or diabetes, the program was actually net cost-saving. This large-scale evaluation provides strong support for integrating medically tailored meals into clinical care for high-risk populations.

In contrast to that clear benefit, a large randomized trial in JAMA Internal Medicine questions the downstream benefits of dementia screening for family members [9]. The trial randomized over 1,800 older primary care patients and their family members to one of three groups: cognitive screening only, screening with a referral for diagnostic follow-up, or a no-screening control. The primary outcome was the family member's health-related quality of life at 24 months. The study found no difference between the screening and no-screening groups on this measure, nor on secondary outcomes like family member depression, anxiety, or caregiver preparedness. The authors suggest a couple of reasons for this null result. First, the rate of positive screens was quite low, at just over 5%. Second, of those who did screen positive and were offered a diagnostic follow-up, more than a third declined to pursue it. These findings suggest that routine screening for Alzheimer's disease and related dementias in primary care may not deliver the expected benefits for family members, nor does it appear to cause them harm.

Finally, two papers from Nature this week, while not immediately practice-changing, shed light on fundamental cancer mechanisms that may influence future therapies. One study identifies spermine, a compound naturally found in the body, as an iron chelator that can inhibit a form of iron-dependent cell death called ferroptosis [3]. This discovery could have implications for treating both liver cancer and ischemia-reperfusion injury in organs like the liver, intestine, and kidneys. A second paper in Nature provides an in-depth look at IDH-mutant gliomas, a type of malignant brain tumor [4]. By integrating multiple layers of genetic and cellular analysis from tumors sampled over time, the researchers mapped out the two main ways these cancers progress and recur after treatment. One pathway involves the acquisition of new genetic mutations, while the other involves a shift toward a more inflammatory, mesenchymal-like state, driven by interactions with immune cells like macrophages. These findings create a roadmap of tumor evolution that could help guide the development of future treatments.

If you only have time for one paper this week, make it the study on medically tailored meals in Nature Medicine [7]. It provides powerful, large-scale evidence from a real-world Medicaid program that prescribing food for patients with diet-related disease and food insecurity significantly reduces hospitalizations and is financially sustainable.

Here are the key takeaways from this week in Family Medicine: First, medically tailored meals for high-risk Medicaid patients with food insecurity are a powerful intervention, significantly cutting hospital and emergency department use at a cost that is nearly fully offset by healthcare savings. Second, in a large randomized trial, routine dementia screening in primary care did not improve quality of life or reduce distress for patients' family members, questioning the downstream benefits of this practice for caregivers. Third, the 50-year global vaccination program has been a monumental public health achievement, providing a 16-fold return on investment and saving countless lives. And fourth, despite this success, major challenges in global health persist, including a shift toward injuries and self-harm as leading killers of youth, and a critical gap between healthcare coverage and the actual quality of care delivered in maternal and newborn services.

That's your roundup for This Week in Family Medicine. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.